It’s disruptive tech in the operating theatre environment, big bucks for each unit and seems to tick all the boxes, like cost savings due to less adverse anesthetiser events that extend hospital stay times etc. Not sure how it will be marketed and therein lies the devil because market penetration will decide how and when it might become a profitable enterprise.
Ann: Investee Cortical Dynamics Update, page-25
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BPH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
-0.001(5.26%) |
Mkt cap ! $20.65M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 2.0¢ | 1.8¢ | $64.19K | 3.434M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 5367878 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 373328 | 8 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| BPH (ASX) Chart |